• Return to Headlines

Ardelyx Inc is Among the Companies in the Biotechnology Industry with the Best Relative Performance (ARDX , RTRX , AMAG , RGEN , EXAS )

By Amy Schwartz

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at yesterday's price action of all companies in this peer group.

Ardelyx Inc (NASDAQ:ARDX ) ranks first with a gain of 0.33%; Retrophin Inc (NASDAQ:RTRX ) ranks second with a loss of 1.00%; and Amag Pharmaceuti (NASDAQ:AMAG ) ranks third with a loss of 1.95%.

Repligen Corp (NASDAQ:RGEN ) follows with a loss of 2.25% and Exact Sciences (NASDAQ:EXAS ) rounds out the top five with a loss of 2.35%.

SmarTrend recommended that subscribers consider buying shares of Retrophin Inc on November 25th, 2019 as our technology indicated a new Uptrend was in progress when shares hit $13.90. Since that recommendation, shares of Retrophin Inc have risen 8.1%. We continue to monitor Retrophin Inc for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: relative performance ardelyx inc retrophin inc amag pharmaceuti repligen corp exact sciences

Ticker(s): ARDX RTRX AMAG RGEN EXAS